Rockwell Medical (NASDAQ:RMTI) Cut to Hold at StockNews.com

StockNews.com cut shares of Rockwell Medical (NASDAQ:RMTI) from a buy rating to a hold rating in a report released on Thursday.

RMTI has been the topic of a number of other research reports. HC Wainwright reissued a “buy” rating and set a $9.00 price objective on shares of Rockwell Medical in a research report on Wednesday, September 11th. RODMAN&RENSHAW upgraded Rockwell Medical to a “strong-buy” rating in a research note on Thursday, November 14th. Finally, Rodman & Renshaw started coverage on Rockwell Medical in a research note on Thursday, November 14th. They set a “buy” rating and a $5.00 price target for the company.

Rockwell Medical Stock Performance

Shares of Rockwell Medical stock opened at $2.25 on Thursday. The company has a current ratio of 2.41, a quick ratio of 2.00 and a debt-to-equity ratio of 0.33. The business has a 50-day moving average price of $3.53 and a two-hundred day moving average price of $2.64. Rockwell Medical has a 1-year low of $1.16 and a 1-year high of $5.15. The company has a market cap of $72.72 million, a P/E ratio of -45.00 and a beta of 1.50.

Institutional Investors Weigh In On Rockwell Medical

Hedge funds have recently modified their holdings of the stock. Concurrent Investment Advisors LLC bought a new stake in shares of Rockwell Medical in the 3rd quarter worth approximately $40,000. Verus Capital Partners LLC bought a new stake in shares of Rockwell Medical in the 3rd quarter worth approximately $51,000. Barclays PLC bought a new stake in shares of Rockwell Medical in the 3rd quarter worth approximately $90,000. Beacon Financial Advisory LLC bought a new stake in shares of Rockwell Medical in the 3rd quarter worth approximately $98,000. Finally, XTX Topco Ltd raised its holdings in shares of Rockwell Medical by 45.7% in the 3rd quarter. XTX Topco Ltd now owns 28,455 shares of the company’s stock worth $113,000 after purchasing an additional 8,922 shares during the period. Institutional investors own 23.31% of the company’s stock.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.